Comerica Bank’s Avadel Pharmaceuticals AVDL Stock Holding History

Comerica Bank’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-58,245	Closed	-$595K	–	2085
2015 Q4	$595K	Sell	58,245 -49,427	-46%	-$771K	0.01%	1640
2015 Q3	$1.76M	Sell	107,672 -143,952	-57%	-$3.17M	0.02%	1096
2015 Q2	$5.33M	Buy	251,624 +147,341	+141%	+$2.64M	0.02%	894
2015 Q1	$1.88M	Sell	104,283 -58,465	-36%	-$915K	0.02%	1128
2014 Q4	$2.79M	Buy	162,748 +97,771	+150%	+$1.4M	0.01%	1283
2014 Q3	$930K	Buy	+64,977	New	+$934K	0.01%	1529

Other funds holding AVDL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Comerica Bank's AVDL Position: Q1 2016 in Review

Comerica Bank sold out of Avadel Pharmaceuticals (AVDL) in Q1 2016, closing a stake of 58,245 shares — an estimated $595K sold.

Comerica Bank first reported a position in AVDL in Q3 2014 and held it in 6 quarters. The position peaked at $5.33M in Q2 2015. 81 funds tracked by Wall St. Rank hold AVDL as of Q1 2016.

Comerica Bank reported no remaining Avadel Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Comerica Bank sold 58,245 Avadel Pharmaceuticals shares in Q1 2016, an estimated $595K.
Comerica Bank first reported a position in Avadel Pharmaceuticals in Q3 2014 and held it in 6 quarters.
Comerica Bank's Avadel Pharmaceuticals position peaked at $5.33M in Q2 2015.
81 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2016.

Based on Comerica Bank's 13F filing for Q1 2016, filed 11 May 2016.